Cladis Investment Advisory, LLC Eli Lilly & CO Transaction History

Cladis Investment Advisory, LLC

  • $144 Billion
  • Q3 2024

A detailed history of Cladis Investment Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cladis Investment Advisory, LLC holds 4,944 shares of LLY stock, worth $3.93 Million. This represents 3.04% of its overall portfolio holdings.

Number of Shares
4,944
Previous 5,844 15.4%
Holding current value
$3.93 Million
Previous $5.29 Billion 17.22%
% of portfolio
3.04%
Previous 3.84%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$772.14 - $960.02 $694,926 - $864,018
-900 Reduced 15.4%
4,944 $4.38 Billion
Q1 2024

Oct 09, 2024
BUY
$592.2 - $792.28 $414,540 - $554,596
700 Added 13.61%
5,844 $4.55 Billion
Q1 2024

May 13, 2024
SELL
$592.2 - $792.28 $602,267 - $805,748
-1,017 Reduced 16.51%
5,144 $4 Million
Q4 2023

Oct 09, 2024
SELL
$525.19 - $619.13 $52,519 - $61,913
-100 Reduced 1.44%
6,861 $4 Billion
Q3 2023

Oct 09, 2024
BUY
$434.7 - $599.3 $789,849 - $1.09 Million
1,817 Added 35.32%
6,961 $3.74 Billion
Q3 2023

Nov 13, 2023
BUY
$434.7 - $599.3 $19,126 - $26,369
44 Added 0.72%
6,161 $3.31 Million
Q1 2023

Oct 09, 2024
BUY
$310.63 - $364.82 $550,746 - $646,825
1,773 Added 34.47%
6,917 $2.38 Billion
Q1 2023

May 15, 2023
BUY
$310.63 - $364.82 $9,318 - $10,944
30 Added 0.49%
6,117 $2.1 Million
Q4 2022

Oct 09, 2024
SELL
$321.55 - $374.67 $73,956 - $86,174
-230 Reduced 3.23%
6,887 $2.52 Billion
Q4 2022

Feb 14, 2023
SELL
$321.55 - $374.67 $9,646 - $11,240
-30 Reduced 0.49%
6,087 $2.23 Million
Q3 2022

Oct 09, 2024
BUY
$296.48 - $337.87 $584,955 - $666,617
1,973 Added 38.36%
7,117 $2.3 Billion
Q3 2022

Nov 17, 2022
BUY
$296.48 - $337.87 $13,934 - $15,879
47 Added 0.77%
6,117 $1.98 Million
Q2 2022

Oct 09, 2024
BUY
$278.73 - $327.27 $536,833 - $630,322
1,926 Added 37.44%
7,070 $2.29 Billion
Q1 2022

Oct 08, 2024
SELL
$234.69 - $291.66 $117,345 - $145,830
-500 Reduced 6.61%
7,070 $2.02 Billion
Q4 2021

Oct 08, 2024
BUY
$224.85 - $279.04 $545,486 - $676,951
2,426 Added 47.16%
7,570 $2.09 Billion
Q4 2021

Oct 01, 2024
BUY
$224.85 - $279.04 $545,486 - $676,951
2,426 Added 47.16%
7,570 $1.68 Billion
Q4 2021

May 10, 2022
BUY
$224.85 - $279.04 $1.36 Million - $1.69 Million
6,070 New
6,070 $1.68 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cladis Investment Advisory, LLC Portfolio

Follow Cladis Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cladis Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email